IMO we're priced fairly reasonably for where we are right now At this end of the market it's extremely common for LOI's and MOU's to amount to nothing. However, as you say, Freshero and Gibio have gone to extreme lengths with us so far. I think it's highly unlikely for either of these Co's to pull the plug on us.
Our valuation is $30-45m MC depending on how many SOI you want to say there are $30m isn't a bad evaluation for a company with extremely little sales to date
I wouldn't say I'm happy, or even OK with where our SP is sitting at the moment, but I can understand why it hasn't yet gone parabolic
If Freshero sign up, Gibio get there first facility up and running this year and we get all licensing done that we need to grow MJ in Canada, then I can see our MC being upwards of $200m
IMO, we should start seeing some real progress towards these 3 big deals over the next month or two & start to build up to that $200m market cap
RGI Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
